Randox International Quality Assessment Scheme – RIQAS at the Point of Care
Designed to improve the quality of Point of Care Testing (POCT) in locations such as pharmacies, GP surgeries, hospital out patient departments, sports clinics, supermarkets, diagnostic/treatment and walk-in centres, RIQAS Point of Care provides independent evidence of the accuracy and reliability of test results. Randox International Quality Assessment Scheme (RIQAS) is the world’s largest EQA scheme with over 45,000 participants in more than 133 countries.
Why RIQAS Point of Care?
Whole blood sample
The RIQAS Point of Care scheme is unique in distributing whole blood rather than serum, mimicking what is typically analysed at the point of care and allowing a truer reflection of analyser performance.
One Sample, One Scheme
A ‘One Sample, One Scheme’ solution means all tests are available from a single sample, avoiding the need to participate in multiple EQA schemes.
Samples are supplied in a convenient ready-to-use format, meaning no preparation is required.
Online User Portal
Our user portal offers an easy-to-use interface for programme registration, result submission, and report retrieval. Users can also add new operators, update contact details and analyser specification.
We provide independent evidence of satisfactory or unsatisfactory performance.
Easy to Use
Our convienient traffic light system ensures reports are easy to interpret and reflect the accuracy and reliability of patients’ results.
Historical reports allow analyser calibration issues to be distinguished from operator performance issues.
We support clients in improving their performance while also providing support to commissioners in performance monitoring and management.
The scheme is suitable for use with all Point of Care Testing (POCT) devices capable of measuring one or more of the following tests: HDL Cholesterol, Total Cholesterol, HbA1c and C-Reactive Protein (CRP).
The scheme enhances patient safety in diagnosis and management of long term conditions.
How it WorksOn a monthly basis we will distribute an identical sample of blood to all participating sites. Each participating site will test the sample in the same way they would test a real patient sample, then return their test results to RIQAS within a set time. The scheme is unique in distributing whole blood samples rather than serum based samples, this ensures that samples act identically to real patient samples at the point of care.An electronic report is then sent to participants, comparing their results with other participants using the same analyser. Satisfactory and unsatisfactory performance is represented using a traffic light system, allowing instant identification of any issues. A more detailed breakdown of performance may be obtained if further information is required. With time, an overall picture will emerge showing whether results are consistently accurate and reliable or whether there may be an underlying analyser and/or operator issue.
Tests and Analysers
Test Role Analysers HbA1c • Diagnosing diabetes mellitus
• Monitoring treatment
• Encouraging self-management
Roche Cobas b101®
Total Cholesterol & HDL Cholesterol • Risk factors for heart disease
• Monitoring lipid lowering therapy
Roche Cobas b101®
C-Reactive Protein (CRP) • Early detection of infectious disease
• Identifying need for antibiotic treatment
Roche Cobas b101®
Panel Catalogue Number Lipids RQ9181/A Lipids + 1 panel RQ9181/B Lipids + 2 panels RQ9181/C Additional Sample RQ9181/D
What Participants Say
Our unrivalled commitment to quality and service ensures high levels of customer satisfaction, this is evident from the responses to our latest customer satisfaction survey:“All in all a quick and efficient service”
“Good online system”
“Very helpful team”
“They are an experienced team”
“Very satisfied with the service that we receive”
“Very good value for money”
“The website is great”
Distribution Month Sample Distributed Result Submission Deadline
March 2019 4th March 11th March April 2019 1st April 8th April May 2019 7th May 14th May June 2019 3rd June 10th June July 2019 1st July 8th July August 2019 5th August 12th August September 2019 2nd September 9th September October 2019 7th October 14th October November 2019 4th November 11th November December 2019 2nd December 9th December
Importance of Quality AssuranceQuality assurance is an essential aspect of any clinical/diagnostic testing service and is aimed at ensuring the accuracy and reliability of patients’ results. The right result allows the right clinical advice to be offered in a timely manner. Quality assurance operates at two levels:
Internal Quality Control
Internal Quality Control includes operator training/ competency assessment, analyser/ test system maintenance, and adherence to policies/ processes. Whilst some point of care analysers include inbuilt quality checks, cross-check analysis against samples with known levels provides immediate assurance and evidence that a patient’s result is safe to report.
External Quality Assessment
External Quality Assessment involves analysis of samples with unknown levels that have been distributed by an external organisation. Participants are informed how their results compare with other participants, hence providing independent evidence of performance. Increasingly, participation in an external quality assessment scheme is becoming a mandatory requirement where health and healthcare services are being provided.
EQA provides assurance to both staff and customers that testing provides accurate and reliable results.
Want to know more?
Visit our Importance of EQA page to learn more